Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FABCY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,294
Award facts
- Contract value 100% obligated
- $16,294.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,294.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 ml pen injections (2 ml units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-competitive, competitively-awarded contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a broad portfolio of brand-name and generic medications, vaccines, and specialized medical devices to support federal military and veteran healthcare systems. DUPIXENT is a biologic immunosuppressant used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions, and its procurement through DLA's medical supply chain ensures availability of this specialized pharmaceutical to Defense Health Agency and other federal healthcare beneficiaries worldwide. The contract award demonstrates AmerisourceBergen's established capability to fulfill federal medical procurement requirements through open competition and reflects its central role as a key pharmaceutical prime vendor within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FABCY?
SPE2DB25FABCY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FABCY worth?
The government has obligated $16,294 on SPE2DB25FABCY.
Is contract SPE2DB25FABCY an order under another contract?
Yes. SPE2DB25FABCY is a delivery order under SPE2DB24D2010, an indefinite delivery contract.
Was contract SPE2DB25FABCY competed?
The extent of competition for SPE2DB25FABCY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award